Central Garden & Pet | 10-K: FY2025 Revenue: USD 3.129 B

LB filings
2025.11.26 15:25

Revenue: As of FY2025, the actual value is USD 3.129 B.

EPS: As of FY2025, the actual value is USD 2.55.

EBIT: As of FY2025, the actual value is USD 282.85 M.

Pet Segment

  • Net Sales: Decreased by $30.8 million, or 1.7%, to $1,802.0 million in fiscal 2025 from $1,832.8 million in fiscal 2024, primarily due to lower sales of durable items impacting outdoor cushions, pet beds, and aquatics businesses, partially offset by increased sales in the animal health business.
  • Operating Income: Increased by $12.3 million, or 6.0%, to $215.7 million in fiscal 2025 from $203.4 million in fiscal 2024, due to improved gross margin and decreased selling, general and administrative expenses, despite lower net sales. Operating margin increased from 11.1% in fiscal 2024 to 12.0% in fiscal 2025.

Garden Segment

  • Net Sales: Decreased by $40.6 million, or 3.0%, to $1,327.1 million in fiscal 2025 from $1,367.7 million in fiscal 2024, primarily due to decreased sales of third-party products and the planned exit of the pottery business, partially offset by increased sales of wild bird feed and private label products.
  • Operating Income: Improved by $60.5 million, or 73.9%, to $142.4 million in fiscal 2025 from $81.9 million in fiscal 2024, due to a $45.3 million increase in gross profit and a $15.2 million decrease in selling, general and administrative expenses, despite a decrease in net sales. Operating margin improved to 10.7% in fiscal 2025 from 6.0% in fiscal 2024.

Cash Flow

  • Operating Cash Flow: Net cash provided by operating activities decreased by $62.4 million, from $394.9 million in fiscal 2024 to $332.5 million in fiscal 2025, primarily due to changes in working capital accounts.

Outlook / Guidance

  • The company anticipates that its sources of liquidity should be adequate to meet its working capital, capital spending, and other cash needs for at least the next 12 months and beyond, based on anticipated cash needs, availability under its asset-backed loan facility, and the scheduled maturity of its debt.